National Pharmaceutical Council
[By Staff Reporters]
The National Pharmaceutical Council’s fourth annual survey of health care stakeholders sheds some light on the environment for comparative effectiveness research (CER) and health care decision-making.
***
***
Questions
- How important is CER?
- Which organizations play key roles in the CER effort?
- How long will it take to see the impact of CER on decision making?
Assessment
Find the answers to these questions and more in this info graphic. (Source: National Pharmaceutical Council, 2014)
Channel Surfing the ME-P
Have you visited our other topic channels? Established to facilitate idea exchange and link our community together, the value of these topics is dependent upon your input. Please take a minute to visit. And, to prevent that annoying spam, we ask that you register. It is fast, free and secure.
More:
- Defining Comparative Medical Effectiveness
- The AHRMM Stance on Comparative Effectiveness Research [CER]
Conclusion
Your thoughts and comments on this ME-P are appreciated. Feel free to review our top-left column, and top-right sidebar materials, links, URLs and related websites, too. Then, subscribe to the ME-P. It is fast, free and secure.
Speaker: If you need a moderator or speaker for an upcoming event, Dr. David E. Marcinko; MBA – Publisher-in-Chief of the Medical Executive-Post – is available for seminar or speaking engagements. Contact: MarcinkoAdvisors@msn.com
OUR OTHER PRINT BOOKS AND RELATED INFORMATION SOURCES:
- PRACTICES: www.BusinessofMedicalPractice.com
- HOSPITALS: http://www.crcpress.com/product/isbn/9781466558731
- CLINICS: http://www.crcpress.com/product/isbn/9781439879900
- ADVISORS: www.CertifiedMedicalPlanner.org
- FINANCE: Financial Planning for Physicians and Advisors
- INSURANCE: Risk Management and Insurance Strategies for Physicians and Advisors
- Dictionary of Health Economics and Finance
- Dictionary of Health Information Technology and Security
- Dictionary of Health Insurance and Managed Care
Filed under: Ethics, Research & Development, Risk Management | Tagged: CER, comparative effective research, National Pharmaceutical Council |















Wait a minute!
CER – Pros and Cons:
http://news.heartland.org/newspaper-article/2009/06/01/comparative-effectiveness-research-pros-cons
Zvi-Bar
LikeLike